Comprehensive US stock backtesting and historical performance analysis to validate investment strategies before committing capital to any trading approach. We provide extensive historical data that allows you to test any trading idea before risking real money in the market. Our platform offers backtesting frameworks, performance attribution, and statistical analysis for strategy validation. Validate your strategies with our professional-grade backtesting tools and comprehensive historical data for better results.
Chimera Investment Corporation 9.000% Senior Notes due 2029 (CIMN) is a publicly traded fixed-income security issued by mortgage real estate investment trust Chimera Investment Corporation. As of 2026-04-13, CIMN trades at a current price of $25.25, posting a minor daily change of -0.18% at the time of writing. No recent earnings data is available for the security, as its performance is tied to fixed coupon payments rather than quarterly corporate operating results, so this analysis relies on pr
What news is impacting Chimera 2029 (CIMN) Stock | Price at $25.25, Down 0.18% - Weak Sell Rating
CIMN - Stock Analysis
3918 Comments
896 Likes
1
Abert
Daily Reader
2 hours ago
Anyone else thinking the same thing?
👍 240
Reply
2
Airelle
Daily Reader
5 hours ago
That’s next-level wizard energy. 🧙
👍 56
Reply
3
Dejounte
Experienced Member
1 day ago
This feels like I’m being tested.
👍 254
Reply
4
Markiece
Registered User
1 day ago
I agree, but don’t ask me why.
👍 270
Reply
5
Hawah
Experienced Member
2 days ago
My respect levels just skyrocketed.
👍 295
Reply
Disclaimer: Not investment advice. For informational purposes only. Past performance does not guarantee future results. Trading involves substantial risk of loss.